China pharmaceutical products over time
US$, annual.
In more detail
| Heading | Value | Share |
|---|---|---|
| 3004 Medicaments | US$11.1 billion | 62.2% |
| 3005 Wadding, gauze, bandages (dressings, adhesive plasters… | US$2.9 billion | 16.4% |
| 3002 Human blood | US$1.7 billion | 9.3% |
| 3003 Medicaments | US$887.6 million | 5.0% |
| 3001 Glands and other organs (extracts, secretions thereof)… | US$693.8 million | 3.9% |
| 3006 Pharmaceutical goods | US$594.3 million | 3.3% |
| Product | Value | Share |
|---|---|---|
| 300490 Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | US$8.1 billion | 45.3% |
| 300590 Wadding, gauze, bandages and similar articles: (excluding adhesive dressings), impregnated or coated with pharmaceutical substances, packaged for retail sale | US$1.8 billion | 9.8% |
| 300439 Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | US$1.5 billion | 8.3% |
| 300290 Toxins, cultures of micro-organisms (excluding yeasts) and similar products | US$1.3 billion | 7.3% |
| 300510 Dressings, adhesive: and other articles having an adhesive layer, packed for retail sale for medical, surgical, dental or veterinary purposes | US$1.2 billion | 6.6% |
| 300190 Glands: heparin and its salts: other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | US$655.4 million | 3.7% |
| 300420 Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | US$649.0 million | 3.6% |
| 300390 Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | US$397.8 million | 2.2% |
| 300410 Medicaments: containing penicillins, streptomycins or their derivatives, for therapeutic or prophylactic uses, packaged for retail sale | US$317.8 million | 1.8% |
| 300320 Medicaments: containing antibiotics other than penicillins, streptomycins and their derivatives, for therapeutic or prophylactic uses, (not in measured doses, not packaged for retail sale) | US$288.0 million | 1.6% |
| Heading | Value | Share |
|---|---|---|
| 3004 Medicaments | US$20.1 billion | 47.9% |
| 3002 Human blood | US$19.7 billion | 47.1% |
| 3006 Pharmaceutical goods | US$1.2 billion | 3.0% |
| 3003 Medicaments | US$435.3 million | 1.0% |
| 3005 Wadding, gauze, bandages (dressings, adhesive plasters… | US$307.7 million | 0.7% |
| 3001 Glands and other organs (extracts, secretions thereof)… | US$82.4 million | 0.2% |
| Product | Value | Share |
|---|---|---|
| 300490 Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | US$14.4 billion | 34.4% |
| 300290 Toxins, cultures of micro-organisms (excluding yeasts) and similar products | US$12.8 billion | 30.7% |
| 300220 Vaccines: for human medicine | US$6.0 billion | 14.3% |
| 300439 Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | US$2.4 billion | 5.7% |
| 300420 Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | US$1.3 billion | 3.1% |
| 300432 Medicaments: containing adrenal cortex hormones (but not containing antibiotics), for therapeutic or prophylactic uses, packaged for retail sale | US$1.2 billion | 2.9% |
| 300210 Blood: human and animal, antisera and other blood fractions | US$707.8 million | 1.7% |
| 300630 Pharmaceutical goods: opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | US$459.0 million | 1.1% |
| 300390 Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | US$419.9 million | 1.0% |
| 300450 Medicaments: containing vitamins or their derivatives, for therapeutic or prophylactic use, packaged for retail sale | US$343.0 million | 0.8% |
Shares are of China's pharmaceutical products in the same direction. See Pharmaceutical products for all countries or all of China's trade.
More China products
- 85 Electrical machinery and equipment and parts thereof
- 84 Machinery and mechanical appliances, boilers, nuclear reactors
- 27 Mineral fuels, mineral oils and products of their distillation
- 26 Ores, slag and ash
- 87 Vehicles
- 39 Plastics and articles thereof
- 94 Furniture
- 73 Iron or steel articles
- 29 Organic chemicals
- 71 Natural, cultured pearls
- 95 Toys, games and sports requisites
- 90 Optical, photographic, cinematographic, measuring, checking, medical or surgical instruments and apparatus
China pharmaceutical products: questions and answers
How much pharmaceutical products does China export?
In 2024, China exported US$17.9 billion of pharmaceutical products (HS chapter 30), 0.5% of its total exports. That ranks it 16 of 213 exporting countries in the data.
What are China's biggest pharmaceutical products exports?
In 2024, the largest 4-digit headings were Medicaments (3004, US$11.1 billion), Wadding, gauze, bandages (dressings, adhesive plasters… (3005, US$2.9 billion), Human blood (3002, US$1.7 billion).
How much pharmaceutical products does China import?
In 2024, China imported US$41.8 billion of pharmaceutical products (HS chapter 30), 1.9% of its total imports. That ranks it 6 of 226 importing countries in the data.
What are China's biggest pharmaceutical products imports?
In 2024, the largest 4-digit headings were Medicaments (3004, US$20.1 billion), Human blood (3002, US$19.7 billion), Pharmaceutical goods (3006, US$1.2 billion).
